Tiger Brokers

US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Moderna, Inc.

197.00
+0.52000.26%
Post-market: 195.74-1.2604-0.64%19:59 EDT
Volume:37.40M
Turnover:7.35B
Market Cap:78.65B
PE:-24.60
High:199.92
Open:196.42
Low:192.71
Close:196.48
52wk High:212.22
52wk Low:22.28
Shares:399.24M
Float Shares:368.05M
Volume Ratio:2.38
T/O Rate:10.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.0076
EPS(LYR):-7.2600
ROE:-39.00%
ROA:-13.26%
PB:11.63
PE(LYR):-27.13

Loading ...

OverviewCompanyNewsFilings

Moderna Shares More than Double on Success of mRNA Cancer Vaccine

Dow Jones
·
Aug 20

Moderna Raised to Outperform from Market Perform by William Blair

Dow Jones
·
Aug 20

Piper Sandler Adjusts Price Target on Moderna to $167 From $77, Maintains Overweight Rating

MT Newswires Live
·
Aug 20

BofA Securities Upgrades Moderna to Neutral From Underperform Following Intismeran 'Success', Raises Price Target to $170 From $40

MT Newswires Live
·
Aug 20

Asia Morning Call-Global Markets

Reuters
·
Aug 20

Top Midday Gainers

MT Newswires Live
·
Aug 20

Jefferies Reaffirms Their Hold Rating on Moderna (MRNA)

TIPRANKS
·
Aug 20

U.S. Stocks on the MOVE-ServiceNow, Zoom, US Homebuilders

Reuters
·
Aug 20

Moderna upgraded to Neutral from Underperform at BofA

TIPRANKS
·
Aug 20

Short Sellers Lose $4.8 Billion as Moderna Stock (MRNA) Soars 150%

TIPRANKS
·
Aug 20

JPMorgan Weighs In on Moderna Stock Amid 140%-Plus Jump (And It Ain’t Pretty)

TIPRANKS
·
Aug 20

US Equity Indexes Rise as Treasury Yields Ease on Buyback Ramp

MT Newswires Live
·
Aug 20

Moderna $30 Bln Gain Implies Many Cancer Successes

Reuters
·
Aug 20

Midday Market Movers: Moderna, Pilgrims Pride, Target, Gold Miners & More

Deep News
·
Aug 20

Moderna Stock (MRNA) Soars 133%; Five-Star William Blair Analyst Says Strong Cancer Data Could Be a Game-Changer

TIPRANKS
·
Aug 20

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
Aug 20

Flash Heard: Why Healthcare is Partying Like It's Late 2020

Dow Jones
·
Aug 20

U.S. Stocks on the MOVE-Marvell, Pilgrim's Pride, ServiceNow

Reuters
·
Aug 19

Top Midday Stories: Treasury Lifts Buyback Cap on Long-Dated Securities; Moderna, Merck Say Melanoma Vaccine Meets Primary Endpoint in Trial

MT Newswires Live
·
Aug 19

Goldman Sachs Adjusts Price Target on Moderna to $120 From $67, Keeps Neutral Rating

MT Newswires Live
·
Aug 19